Volume 17, Number 2—February 2011
Dispatch
Novel HIV-1 Recombinant Forms in Antenatal Cohort, Montreal, Quebec, Canada
Table
Patient | Age, y | CD4 count, cells/mm3 | Viral load, RNA copies/mL | Antiretroviral treatment |
---|---|---|---|---|
TV721 | 33.2 | 210 | 164 | AZT-3TC-NVP |
TV725 | 30.1 | 816 | 739 | None |
TV749 | 34.1 | 198 | 23,369 | AZT-3TC-NFV |
TV919 | 34.0 | 420 | 1,910 | AZT-3TC-NFV |
*AZT, zidovudine; 3TC, lamivudine; NVP, nevirapine; NFV, nelfinavir.
Page created: July 08, 2011
Page updated: July 08, 2011
Page reviewed: July 08, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.